Stone R A, Zimmerman T J, Shin D H, Becker B, Kass M A
Am J Ophthalmol. 1977 May;83(5):674-9. doi: 10.1016/0002-9394(77)90134-9.
Sixteen patients with increased intraocular pressure (over 20 mm Hg) received 25 and 50 mg of oral methazolamide, twice daily, during consecutive weeks and then 500 mg (Sequels) of acetazolamide. The two methazolamide regimens produced significant decreases in intraocular pressure. Acetazolamide treatment resulted in a greater decrease in intraocular pressure but more systemic acidosis and side effects.
16名眼压升高(超过20毫米汞柱)的患者连续数周每天两次接受25毫克和50毫克的口服醋甲唑胺治疗,然后接受500毫克(续发)乙酰唑胺治疗。两种醋甲唑胺治疗方案均使眼压显著降低。乙酰唑胺治疗使眼压降低幅度更大,但全身酸中毒和副作用更多。